Tarbox Family Office’s Lisata Therapeutics LSTA Stock Holding History

Tarbox Family Office’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-769	Closed	-$6K	–	95
2022 Q2	$6K	Buy	+769	New	+$6.33K	﹤0.01%	107
2019 Q2	–	Sell	-769	Closed	-$42K	–	1111
2019 Q1	$42K	Hold	769	–	–	0.02%	157
2018 Q4	$41K	Hold	769	–	–	0.02%	157
2018 Q3	$68K	Buy	+769	New	+$63K	0.02%	137
2018 Q2	–	Sell	-6,444	Closed	–	–	627
2018 Q1	$0	Hold	6,444	–	–	﹤0.01%	636
2017 Q4	$0	Hold	6,444	–	–	﹤0.01%	620
2017 Q3	$0	Hold	6,444	–	–	﹤0.01%	612
2017 Q2	$0	Buy	+6,444	New	+$455K	﹤0.01%	596
2014 Q4	–	Sell	-644	Closed	-$535K	–	565
2014 Q3	$535K	Buy	+644	New	+$564K	0.48%	30

Other funds holding LSTA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cook Wealth Raleigh, North Carolina $206M AUM 4.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tarbox Family Office's LSTA Position: Q3 2022 in Review

Tarbox Family Office sold out of Lisata Therapeutics (LSTA) in Q3 2022, closing a stake of 769 shares — an estimated $6K sold.

Tarbox Family Office first reported a position in LSTA in Q3 2014 and held it in 9 quarters. The position peaked at $535K in Q3 2014. 22 funds tracked by Wall St. Rank hold LSTA as of Q3 2022.

Tarbox Family Office reported no remaining Lisata Therapeutics position as of Q3 2022 after selling out during the quarter.
Tarbox Family Office sold 769 Lisata Therapeutics shares in Q3 2022, an estimated $6K.
Tarbox Family Office first reported a position in Lisata Therapeutics in Q3 2014 and held it in 9 quarters.
Tarbox Family Office's Lisata Therapeutics position peaked at $535K in Q3 2014.
22 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2022.

Based on Tarbox Family Office's 13F filing for Q3 2022, filed 14 Oct 2022.